Biosimilars Will Foster Competition and Lower Costs

In both of his administrations, President Trump promoted most-favored nation (MFN) pricing as a way to bring down drug costs in the United States. On July 31, 2025, President Trump sent letters to 17 pharmaceutical manufacturers demanding that they implement MFN prices or face the consequences.

In June, the Academy of Managed Care Pharmacy (AMCP) convened leading experts from across health care disciplines for a two-day Precision Medicine Partnership Forum. The forum aimed to advance equitable and timely access to precision medicine, particularly in oncology.

On October 27, 2025, AMCP will host its inaugural Pharmacy Policy Summit at the Gaylord National Harbor. It is shaping up to be a must-attend event for anyone invested in the future of managed care pharmacy on the Hill and beyond.